LANGUAGES

Innovations

Production

Home innovations production

Our highly qualified production staff works diligently to produce our product range to the highest quality norms. Our 2000m2 manufacturing facility and 620m2 cleanroom utilize state-of-the-art technology in various assembly, packaging, and sterilization operations as well as our own, unique production lines for more sophisticated IV sets. Our current capacity is 20 million units of SwabArt® disinfection caps and 60 million units of FlowArt® and NeutrArt® needle-free connectors with further room to grow in the near future

 

The new state-of-the-art production facilities are located
in Istanbul, covering an area of

2000m²

FACTORY

with
620m²

CLEAN ROOM

capabilities.

Our warehouse has a highly trained dedicated logistics team, delivering optimal shipment solutions especially in the wake of global logistics troubles. We distribute over 30 million products annually to over 40 countries globally thanks to our ever-expanding global footprint. Asset Medical’s product and service quality is widely recognized by independent healthcare agencies as our products are certified for CE, FDA, ANVISA, TGA accreditations.

This capacity allows us to produce

60M
 

Individual needle-free valves

10M

Assemblies

Ranking us as one of the largest and most modern needle-free valve producers worldwide. Offering creative,
innovative, cost efficient and high quality Disposable Infusion Products, OEM Products and Components by
following the guiding institutions and publications in this field.

 
 
 

NeutrArt®

Neutral Displacement Needle-Free Connectors

FlowArt®

Needle-Free Valves

SwabArt®

Disinfection Caps
C100 Disinfecting caps in strip form
C200 Disinfecting caps in individual form

 
 

FlowArt®

One Directional Needle-Free Valves

FlowArt®

Vial and Bag Adapters

FlowArt®

IV-Filters

 

FlowArt®

Photo Protective Needle-Free Valves

 
Production
REQUEST
FORM
 

LATEST NEWS

ALL NEWS +
Asset Medical Announces New CEO Appointment to Lead Growth and Innovation in Medical Device Industry
September 14, 2023

Asset Medical Announces New CEO Appointment to Lead Growth

Progressive Medical, Inc and Asset Medical Join Forces to Deliver Innovative Infusion Therapy & Improve Patient Outcomes
September 12, 2023

Progressive Medical, Inc and Asset Medical Join Forces to Deliver Innovative Infusion Therapy & Improve Patient Outcomes

Asset Medical received 510(k) regulatory clearance from the U.S. Food and Drug Administration for a range of our Sterile Infusion Therapy Products stating very high-pressure resistance of 400 psi at 10 ml/sec fluid flow
January 16, 2023

FlowArt® Sterile Infusion Therapy Devices including Needle-free IV Connectors, Extension sets and IV high pressure was recently approved by U.S. Food

Asset Medical is proud to announce a brand new NeutrArt® Neutral Displacement Needle-Free Connector.
October 01, 2021

Asset Medical is proud to announce a brand new NeutrArt® Neutral Displacement Needle-Free Connector.

Asset is proud to announce that FlowArt® Sterile Infusion Therapy Devices range has been approved by U.S. Food and Drug Administration in March 2020
March 01, 2020

FlowArt® Sterile Infusion Therapy Devices including Needle-free IV Connectors, Extension sets and I.V. Filter sets has been approved by U.S. Food and